Mayo Clinic Labs
  • MayoACCESS
  • MayoLINK
  • Register
  • My Dashboard
  • Algorithms
  • Download Test Catalog & Interpretive Handbook
  • New Tests
  • NY State Informed Consent Tests
  • Performing Locations
  • Referred Tests
  • Specialty Testing
  • Test Updates
  • Critical Values & Results
  • Custom Gene Ordering
  • Forms
  • LIS Resources
  • MayoACCESS Resources
  • MayoLINK Resources
  • Order Your First Test
  • Patient Information and Signature Forms
  • Request Additional Testing
  • Send Additional Specimen
  • Collection & Preparation
  • Dangerous Goods Training
  • Shipping & Courier Guides
  • Shipping Regulations
  • Supplies
  • Billing
  • Contact Us
  • FAQ
  • IT Updates
  • Operational Updates
  • Quality & Compliance
  • Educational Resources
  • News
  • Outreach
  • Podcasts
  • Stories
  • Contact
  • Log Out
Insights
  • Education
  • News
  • Podcasting
  • Stories
A journey to diagnosis: One patient’s story of resilience and hope

For many, the path to a correct diagnosis can be long and filled with uncertainty. This story highlights the resilience and determination of one patient who navigated a complex medical journey to find answers and hope at Mayo Clinic. The patient asked to remain anonymous for personal privacy reasons.

May 5, 2025
Streamlining lab visits: Can patient self-collected blood improve the phlebotomy experience?
September 10, 2025

PACE/State of FL - Register now – Sept. 10, 2025

Expanded Pancreatitis Gene Panel (PANGP)
July 8, 2025

Clinically relevant overview of key genetic factors, testing strategies, and post-result care.

Preventing Unnecessary Fireworks: Resolving Conflict in the Workplace
July 7, 2025

Conflict is a natural part of human interaction, and the workplace is not immune from that experience.  Through this microlearning, we'll explore how proper conflict[...]

Get to Know DLMP’s Vice Chair of Research: Peter Lucas, M.D., Ph.D.
May 30, 2024

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Peter Lucas, M.D., Ph.D., vice chair of Research for the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic.

Celiac Disease: Diagnostic Testing Algorithms
May 30, 2024

This three-part microlearning series is designed for healthcare professionals interested in understanding the diagnostic algorithms for celiac disease.

Managing Outpatient Interactions Beyond the Phlebotomy Setting
May 28, 2024

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton. They discuss how to proactively manage the variety of patient requests and interactions that occur in an outreach laboratory beyond the phlebotomy environment.

Oncology surveillance biomarker study enrolls patients and evaluates assay
May 27, 2024

Mayo Clinic Laboratories’ BioPharma Diagnostics team supports companies from discovery to post-market in advancing their precision medicine initiatives. In this collaboration example, learn how BioPharma Diagnostics helped a biotech company complete a surveillance biomarker study to establish a cutoff for its assay developed to monitor the progression or regression of disease in patients with well-defined gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D.
May 23, 2024

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of laboratory medicine and pathology and clinical virologist at Mayo Clinic. They discuss the widespread outbreaks of H5N1 bird flu and the new “FLiRT” variants of COVID-19.

Establishing a trusted lab partner in an evolving landscape
May 22, 2024

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, authored a Becker’s Healthcare article on how hospital laboratories can navigate times of change and uncertainty with the steadfast support of a business partner like Mayo Clinic Laboratories.

Mayo Clinic Laboratory and Pathology Research Roundup: May 21
May 21, 2024

This week's research roundup feature: Monoclonal immunoglobulin (MIg) crystalline nephropathies are rare lesions resulting from precipitation of MIgs in the kidney as crystalline inclusions. They can be categorized into lesions with predominant intracellular crystals (light chain [LC] proximal tubulopathy, LC crystal-storing histiocytosis, LC crystalline podocytopathy] and lesions with predominant extracellular crystals (crystalglobulin-induced nephropathy, crystalline variant of LC cast nephropathy).

Enhanced Solid Tumor NGS Panel Broadens Genetic-Variants Detection: Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S.
May 21, 2024

Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S., explain how Mayo Clinic Laboratories' enhanced MayoComplete Solid Tumor Panel better profiles tumor genetics. Defining tumor pathogenesis can guide targeted cancer therapy.

Managing patient expectations for home specimen collection
May 20, 2024

When patients are tasked with collecting specimens at home, the procedure can require special timing, collection steps, or storage conditions. If these aren’t clearly communicated to the patient beforehand, it can lead to confusion and unnecessary frustration. A laboratory can set up its patients for success by managing expectations when home collections are necessary. These steps can help ensure a successful experience for both patients and laboratory staff.

Breathing Easier: Immunotherapies for Asthma and Allergy
May 17, 2024

In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., interviews Douglas McMahon, M.D., from the Allergy and Asthma Center of Minnesota, to discuss how the lab supports asthma and allergy medical practice.

New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D.
May 14, 2024

Rapidly progressive dementia (RPD) is an umbrella term covering many devasting conditions, including Creutzfeldt-Jakob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' unique RPD evaluation and new CJD test help pinpoint diagnosis, to guide prognosis and treatment decisions.

Mayo Clinic Laboratory and Pathology Research Roundup: May 14
May 14, 2024

This week's research roundup feature: Despite advances in understanding the genetic abnormalities in myeloproliferative neoplasms (MPNs) and the development of JAK2 inhibitors, there is an urgent need to devise new treatment strategies, particularly for triple negative myelofibrosis (MF) patients who lack mutations in the JAK2 kinase pathway and have very poor clinical outcomes.

View MoreView Less
Mayo Clinic Labs
Mayo Clinic Labs
  • Mayo Clinic
  • About us
  • BioPharma
  • Cardiovascular services
  • Newsroom
Resources
  • FAQ
  • Policies
  • Quality
  • Careers
  • Insights
  • Terms of use
  • Privacy statement
Accounts
  • Mayo account
  • MayoLINK
  • Register
  • Dashboard
  • Log out
Contacts
  • Contacts
  • Customer service
Facebook Twitter Instagram LinkedIn YouTube
© 1995–2025 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.